| MolName | (E)-3-(4-morpholin-4-ylsulfonylphenyl)-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)prop-2-enamide |
| MolecularFormula | C21H20N4O4S2 |
| Smiles | O=C(/C=C/c(cc1)ccc1S(N1CCOCC1)(=O)=O)Nc1nc(-c2ccncc2)cs1 |
| InChI | InChI=1S/C21H20N4O4S2/c26-20(24-21-23-19(15-30-21)17-7-9-22-10-8-17)6-3-16-1-4-18(5-2-16)31(27,28)25-11-13-29-14-12-25/h1-10,15H,11-14H2,(H,23,24,26) |
| InChIK | BIYRUQMFHQKPQJ-UHFFFAOYSA-N |
| TotalMolweight | 456.546 |
| Molweight | 456.546 |
| MonoisotopicMass | 456.092596 |
| CLogP | 2.5537 |
| CLogS | -3.42 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 332.37 |
| Relative PSA | 0.32774 |
| PolarSurfaceArea | 138.11 |
| Druglikeness | 2.9067 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | limit! thiazol-2-ylamine |
| Shape Index | 0.64516 |
| Fragments | 1 |
| Non HAtoms | 31 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 5 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 6 |
| Symmetricatoms | 7 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (E)-3-(4-morpholin-4-ylsulfonylphenyl)-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)prop-2-enamide | 2 - (E)-3-(4-morpholin-4-ylsulfonylphenyl)-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)prop-2-enamide